Page 7 of 8
CM19.1-4 | Essential Medicine — Assignment
Grading Rubric — Essential Medicine Assignment Rubric
| Criterion | Points | Full-marks descriptor |
|---|---|---|
| CM19.1 — EML concept and access framework (Section 1) | 5 pts | Exceeds: Accurately identifies all four WHO access dimensions, maps specific PHC failures to each dimension, and cites NLEM 2022 selection criteria with specific examples. |
| CM19.3 — Drug quality classification and regulatory response (Section 2) | 5 pts | Exceeds: Correctly classifies suspect Amoxicillin as falsified (with justification), proposes immediate quarantine + sample testing, and correctly identifies CDSCO/state drug controller notification pathway via pharmacovigilance system. |
| CM19.4 — Drug requirement calculation (Section 3) | 5 pts | Exceeds: Correctly applies stock-out correction (÷ 0.75 or equivalent), growth adjustment (×1.20), and buffer (×1.15) with all steps shown. Final figure: ~5,893 sachets. Defines consumption method and buffer stock correctly. |
| CM19.2 + CM19.1 — Rational use indicators and P-drug concept (Section 4) | 5 pts | Exceeds: Names three valid WHO/HAI essential medicines performance indicators, accurately explains P-drug concept with an example from the PHC formulary, and correctly links DPCO/NPPA to procurement affordability advocacy. |